Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from... see more

TSXV:DM - Post Discussion

Datametrex AI Ltd > DELTA VARIANT...
View:
Post by MoreUpThanDown on Jun 10, 2021 9:24am

DELTA VARIANT...

... means testing is far from over......... https://www.ctvnews.ca/health/coronavirus/delta-coronavirus-variant-believed-to-have-60-per-cent-transmission-advantage-u-k-epidemiologist-1.5462774 ..... Delta coronavirus variant believed to have 60 per cent transmission advantage: U.K. epidemiologist | CTV News.......... LONDON -- The Delta coronavirus variant of concern, first identified in India, is believed to be 60% more transmissible than the Alpha variant which was previously dominant in Britain, a prominent UK epidemiologist said on Wednesday. British Prime Minister Boris Johnson has said that England's full reopening from COVID-19 lockdown, penciled in for June 21, could be pushed back due to the rapid spread of the Delta variant. Neil Ferguson of Imperial College London told reporters that estimates of Delta's transmission edge over Alpha had narrowed, and "we think 60% is probably the best estimate." Ferguson said that modeling suggested any third wave of infections could rival Britain's second wave in the winter - which was fueled by the Alpha variant first identified in Kent, south east England. But it was unclear how any spike in hospitalisations would translate into a rise in deaths, as more detail was needed on how well the vaccine protects against serious illness from Delta. "It's well within possibility that we could see another third wave at least comparable in terms of hospitalisations," he said. "I think deaths probably would be lower, the vaccines are having a highly protective effect... still it could be quite worrying. But there is a lot of uncertainty." Britain has seen over 127,000 deaths within 28 days of a positive COVID-19 test, but has given more than three-quarters of adults a first dose of COVID-19 vaccine. Public Health England has shown that the Delta variant reduces the effectiveness of Pfizer and AstraZeneca shots among those who have only received one shot, though protection is higher for those who have received both doses. Ferguson said that up to a quarter of the Delta variant's transmissibility edge over Alpha might come from its immune escape from vaccines, saying it was "a contribution but not an overwhelming contribution" to its advantage.
Comment by Smiles62 on Jun 10, 2021 9:39am
In at 0.23
Comment by frewil11 on Jun 10, 2021 10:20am
Well the market is typically forward looking and 90% of DM's revenue is from Covid , so we most likely will see more weakness until a good AI contract or two gets signed. JMHO
Comment by shaker13 on Jun 10, 2021 10:51am
What Could Go Wrong https://www.cnbc.com/2021/06/10/covid-vaccine-cdc-says-heart-inflammation-cases-in-16-to-24-year-olds-higher-than-expected-after-second-shot.html
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities